Sentences with phrase «when pharmaceutical»

When pharmaceutical companies got on the bandwagon, convincing insurers and consumers alike that medication could fix mental health, the pressure mounted to think about «curing» our clients.

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie.

Ideally, when your pharmaceutical sales interview is scheduled, the recruiter or hiring manager will tell you everything you need to know.

The week before your pharmaceutical sales interview: Ideally, when your pharmaceutical sales interview is scheduled, the recruiter or hiring manager will tell you everything you need to know.

When a pharmaceutical company places the public at risk like this, they must be held accountable for their negligent, dangerous conduct.

When pharmaceutical and medical device giants, such as J&J, put profits before the health and safety of the public, they should be held accountable for their actions.

When pharmaceutical companies fail to warn about side effects, or neglect to perform proper testing on drugs before marketing them for certain uses, it can result in injury and death.

When pharmaceutical companies promote drugs and medical devices, or take advantage of «off - label» use by repurposing a medicine's original treatment without the necessary testing, it puts the public at risk.

When pharmaceutical companies put profits before the health and safety of the general public, they should be held accountable for those actions.

When pharmaceutical companies put profits before the health and safety of the general public, they should be held accountable for their negligent actions.

When pharmaceutical companies put profits over the health and well - being of the public, they should be held accountable.

When pharmaceutical companies put profits before the health and safety of patients, they should be held accountable.

When pharmaceutical giants like AstraZeneca don't do their proper work to ensure the lasting safety of their customers, we hold them accountable.

When pharmaceutical companies and medical products manufacturers put profits before the health and safety of the general public, they should be held accountable for their actions.

When pharmaceutical companies put profits before the health and safety of the public, they should be held accountable for their actions.

When pharmaceutical companies put profits before the health and well - being of patients, they should be held accountable for those actions.

When a pharmaceutical salesperson hands a clinician an article reprint, the name of the institution on the front page of the reprint serves as a stamp of approval.

The use of colloidal silver as medicine has been around since the BC era, and was physicians» go - to treatment for infections up until the mid-1950s when pharmaceutical antibiotics were introduced to the market.

The health - giving activities practiced at Inner Fire offer real hope at a time when pharmaceutical solutions have fallen so far short of what is needed to help individuals become their healthy selves once again.

Anticipation built in 2013 when pharmaceutical giant Roche announced a partnership with Ionis to develop the ASO drug for HD, which they call * IONIS - HTT Rx *.

«The Lobotomist» raises questions that remain urgently relevant in an age when pharmaceutical companies help define what it means to be mentally ill.

Choosing a career in industry may seem risky at a time when the pharmaceutical industry has shed many scientific jobs as a result of the global recession and looming restructuring of the drug - development process.

When the pharmaceutical companies that produce birth control products offer the CC a piece of the action, the church will «reconsider» their stance in a heartbeat.

Now Mylan appears to be learning the same hard lesson this week that Martin Shkreli and Valeant (vrx) learned last year: Investors love when pharmaceutical companies raise drug prices — until everybody else gets really upset about it.

Not exact matches

By contrast, while the cost of older, branded pharmaceuticals continue to rise and contribute to increased spending, when discounting is considered, prices of these drugs increased, on average, 2.8 % in 2015, the lowest growth rate in years.

On average, the 30 large and small pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue from drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.

Papa's assurances lost some weight however when reports emerged two days later that the company was still under criminal investigation for potential insurance fraud related to its ties to specialty pharmaceutical Philidor — which erased all of the stock's recent gains.

A former rail depot, the «Umekita Phase 2» development now under construction next to Osaka Station is set to host pharmaceutical and biotech firms when it opens around 2024.

If you haven't followed this story, you'll remember Shkreli from his fame two years ago, when his biotech firm, Turing Pharmaceuticals, acquired the patent to a drug used to treat malaria, cancer and aids, and jacked up the retail price by more than 5,000 percent.

Activist investor and hedge fund manager John Paulson has joined Valeant Pharmaceuticals International's board, a move that comes at a time when the embattled Canadian drugmaker is restructuring itself to repay debt.

Novum has steadily increased its price since that time, when it acquired the drug from Primus Pharmaceuticals, its previous owner.

Some have started charging mid-size corporate customers, who employ 2,000 to 10,000 people, additional fees for integrating medical claims and pharmaceutical claims when they are managed by different companies, Dross said, and could require those fees for larger clients as well.

How about buying a global pharmaceutical company Sterling Drug when you are Eastman Kodak?

Andrew Ritter, Ritter Pharmaceuticals When doctors told Andrew Ritter that he would never be able to eat dairy foods, Ritter decided he loved ice cream too much to accept that.

When it comes to the big screen, Wall Streeters fall in a category with pharmaceutical manufacturers and oil company executives — untouchably unsympathetic.

The 32 - year - old CEO of Turing Pharmaceuticals became a target of widespread ire in September when he boosted the price of the toxoplasmosis treatment Daraprim by over 5,000 % after acquiring the drug in August.

He has since gone long on Valeant, saying such «platform companies» — those that grow through bolt - on acquisitions — enrich their shareholders with each new deal, as Valeant did when it acquired Salix Pharmaceuticals earlier this year (Valeant shares are up 49 % since then).

Salix Pharmaceuticals, which Valeant itself bought last year, did not have a permanent CEO when the deal was announced, but its acting CEO at the time, Thomas D'Alonzo, likely already knows Valeant pretty well.

And the defiant stance actually may have boosted the drug maker's image at a time when Americans are skeptical about the pharmaceutical industry over high drug prices.

The U.S. pharmaceutical giant failed once before, after all, when it attempted a tax inversion with the U.K. firm AstraZeneca earlier this year.

Her company, Sprout Pharmaceuticals, made headlines in August when a drug it created became the first FDA approved drug to boost a woman's sex drive.

When Bristol - Myers and Squibb merged in 1989, they formed the world's second - largest pharmaceutical company (and something more: Bristol - Myers brands included Drano, Windex, and Clairol).

At a moment when the world's fourth - largest pharmaceutical company by sales (Pfizer) is eagerly courting the world's ninth - largest (the very same AstraZeneca from which Bristol decoupled)-- offering, in late May, a monumental dowry of around $ 120 billion — one can be forgiven for not noticing the more substantive change that's sweeping the pharmaceutical industry: Big Pharma is getting smaller.

In the late 1990s, when Alpheus Bingham, a veteran with American pharmaceutical giant Eli Lilly, came up with the idea for InnoCentive, the terms «open innovation» and «crowdsourcing» didn't even exist.

In fact, when pressed on the issue, Verheul speculated that perhaps costs would not increase since Canadians already pays higher prices for pharmaceutical drugs than consumers in European countries such as the UK, France or Germany.

World - class asshole Martin Shkreli found himself in the news yet again when he resigned his position as CEO at Turing Pharmaceuticals.

Similarly, when Pershing Square Capital and Valeant Pharmaceuticals made a bid for Allergan last year, Valeant announced that, if successful, it would cut R&D at the combined firm by 69 %.

David Pyott had been the CEO of Allergan for nearly 17 years in April 2014, when Valeant Pharmaceuticals and Pershing Square Capital Management initiated the hostile takeover bid described in the accompanying article «The Error at the Heart of Corporate Leadership.»

When he learned he was under criminal investigation by the FBI, Turing Pharmaceuticals CEO Martin Shkreli could have kept a low profile and gone to the Caribbean.

Bayer said in a statement that it doesn't control the cost for patients at the pharmacy, because copays are determined by insurers and pharmacy - benefit managers — an argument that pharmaceuticals companies have long made when facing criticism over drug prices.